Syra Health Corp.
SYRA
$0.07
-$0.01-11.19%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -13.27% | 4.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.27% | 4.76% | |||
| Cost of Revenue | -5.02% | -5.94% | |||
| Gross Profit | -26.35% | 27.78% | |||
| SG&A Expenses | 0.01% | -23.38% | |||
| Depreciation & Amortization | -10.00% | -11.76% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.44% | -13.80% | |||
| Operating Income | -267.41% | 86.65% | |||
| Income Before Tax | -255.19% | 86.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -255.19% | 86.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -255.19% | 86.53% | |||
| EBIT | -267.41% | 86.65% | |||
| EBITDA | -296.50% | 87.74% | |||
| EPS Basic | -256.60% | 87.01% | |||
| Normalized Basic EPS | -257.58% | 87.06% | |||
| EPS Diluted | -256.60% | 87.01% | |||
| Normalized Diluted EPS | -257.58% | 87.06% | |||
| Average Basic Shares Outstanding | 0.00% | 3.04% | |||
| Average Diluted Shares Outstanding | 0.00% | 3.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||